Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

TLA Targeted Immuno Therapies AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 40 More Arrow 179 Less Arrow 178
Financial expenses 111 Less Arrow 73 Less Arrow 66
Earnings before taxes -971 More Arrow -827 More Arrow -620
EBITDA -568 More Arrow -518 More Arrow -479
Total assets 2,675 More Arrow 2,682 More Arrow 2,901
Current assets 433 More Arrow 534 More Arrow 651
Current liabilities 3,568 Less Arrow 2,246 Less Arrow 1,602
Equity capital -1,997 More Arrow -1,024 More Arrow -214
- share capital 24 Equal arrow 24 More Arrow 26
Employees (average) 4 Equal arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -74.7% More Arrow -38.2% More Arrow -7.4%
Turnover per employee 10 More Arrow 45 Less Arrow 44
Profit as a percentage of turnover -2427.5% More Arrow -462.0% More Arrow -348.3%
Return on assets (ROA) -32.1% More Arrow -28.1% More Arrow -19.1%
Current ratio 12.1% More Arrow 23.8% More Arrow 40.6%
Return on equity (ROE) 48.6% More Arrow 80.8% More Arrow 289.7%
Change turnover -139 More Arrow 16 Less Arrow -1,384
Change turnover % -78% More Arrow 10% Less Arrow -89%
Chg. No. of employees 0 Equal arrow 0 Less Arrow -2
Chg. No. of employees % 0% Equal arrow 0% Less Arrow -33%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.